Outcome Assessment in Patients Treated With Hyperbaric Oxygen Using OxyVu Tissue Oxygenation Monitoring System

Outcome Assessment in Patients Treated With Hyperbaric Oxygen Using OxyVu Tissue Oxygenation Monitoring System

The objective is to define patient eligibility for hyperbaric oxygen therapy and to evaluate wound healing progression using a new hyperspectral imaging technology.

The purpose of this clinical study is to define patient eligibility for hyperbaric oxygen therapy (HBOT) and to evaluate wound healing progression during HBOT using a new hyperspectral imaging technology (OxyVu).

Inclusion criteria:

• 18 - 85 years of age
• Patients with wounds that meet the criteria for hyperbaric oxygen therapy (e.g. problem wound, diabetic foot ulcer, necrotizing soft tissue infections)
• Compromised Flap or Grafts.

Exclusion criteria:

• Patients with poor cardiac output (EF < 20%)
• Patients with severe obstructive pulmonary disease who don't qualify for HBOT
• Patients with untreated asthma who don't qualify for HBOT
• Patients utilizing supplemental oxygen and those on ventilators
• Patients on life support medications (pressors)